Nida
-
Blocking stress-induced relapse
Danny Winder and colleagues are teasing apart the actions of neurotransmitter receptors in a brain region linked to anxiety and addiction, with a goal of finding treatments for substance use disorders. Read MoreApril 8, 2020
-
Cell fate signaling
A newly identified protein interaction that affects cell cycle regulation may be an attractive target for cancer therapy. Read MoreDecember 17, 2019
-
Defective transporter linked to autism
A first-of-its-kind mouse model may help reveal mechanistic underpinnings for the altered behaviors of autism spectrum disorder. Read MoreJuly 24, 2019
-
Modulating stress circuits
Danny Winder and colleagues have demonstrated how norepinephrine and a stress factor call CRF interact, which may lead to new treatments for stress-related disorders. Read MoreFebruary 15, 2019
-
Immune system emerges as partner in opioid cravings fight
There’s promise in specific immune system peptides—amino acid compounds that signal cells how to function. In this case, they may be affecting brain activity and, by extension, drug cravings. Read MoreSeptember 5, 2018
-
Investigators find that bile acids reduce cocaine reward
The discovery that high levels of bile acids appear to blunt cravings for cocaine could lead to new treatments for addiction. Read MoreAugust 30, 2018
-
Shaping reward circuits
Using techniques to control and monitor the activities of individual neurons, Vanderbilt investigators are probing the brain’s reward circuitry. Read MoreMay 18, 2018
-
An immune regulator of addiction
Although drug addiction is classically studied in a neuron-centric way, Vanderbilt researchers have discovered that the immune system also plays a critical role. Read MoreAugust 4, 2017
-
Diabetes drugs may ease addiction
Drugs that are being used clinically to treat obesity and diabetes may also have a role in treating drug abuse. Read MoreJuly 18, 2016
-
New pain medicine from a fungus?
Collybolide – a natural product isolated from a mushroom – is a promising candidate for the development of non-addictive pain medicines. Read MoreMay 13, 2016